| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.089 | 0.6 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |